Detalhe da pesquisa
1.
Superior immunogenicity and effectiveness of the third compared to the second BNT162b2 vaccine dose.
Nat Immunol
; 23(6): 940-946, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35534723
2.
SARS-CoV-2 IgG Levels as Predictors of XBB Variant Neutralization, Israel, 2022- and 2023.
Emerg Infect Dis
; 30(5): 1050-1052, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38666742
3.
Waning Immune Humoral Response to BNT162b2 Covid-19 Vaccine over 6 Months.
N Engl J Med
; 385(24): e84, 2021 12 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34614326
4.
The Association Between Prebooster Vaccination Antibody Levels and the Risk of Severe Acute Respiratory Syndrome Coronavirus 2 Infection.
Clin Infect Dis
; 76(7): 1315-1317, 2023 04 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36366729
5.
Association between Thrombin Generation and Clinical Characteristics in COVID-19 Patients.
Acta Haematol
; 146(2): 151-160, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36273451
6.
Early Immunogenicity and Safety of the Third Dose of BNT162b2 Messenger RNA Coronavirus Disease 2019 Vaccine Among Adults Older Than 60 Years: Real-World Experience.
J Infect Dis
; 225(5): 785-792, 2022 03 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34850049
7.
Comparing immunogenicity and efficacy of two different mRNA-based COVID-19 vaccines as a fourth dose; six-month follow-up, Israel, 27 December 2021 to 24 July 2022.
Euro Surveill
; 27(39)2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36177870
8.
Potential Antigenic Cross-reactivity Between Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Dengue Viruses.
Clin Infect Dis
; 73(7): e2444-e2449, 2021 10 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32797228
9.
Low FXIII activity levels in intensive care unit hospitalized COVID-19 patients.
Thromb J
; 19(1): 79, 2021 Nov 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34736472
10.
Six-Month Follow-up after a Fourth BNT162b2 Vaccine Dose.
N Engl J Med
; 387(22): 2092-2094, 2022 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36351266
11.
Efficacy of a Fourth Dose of Covid-19 mRNA Vaccine against Omicron.
N Engl J Med
; 386(14): 1377-1380, 2022 04 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35297591
12.
Intranasal telmisartan ameliorates brain pathology in five familial Alzheimer's disease mice.
Brain Behav Immun
; 64: 80-90, 2017 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-28385651
13.
Differential effect of intranasally administrated kinin B1 and B2 receptor antagonists in Alzheimer's disease mice.
Biol Chem
; 397(4): 345-51, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-26556847
14.
Presence of SARS-CoV-2 antibodies in lactating women and their infants following BNT162b2 messenger RNA vaccine.
Am J Obstet Gynecol
; 225(5): 577-579, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34352250
15.
Immunogenicity and Reactogenicity of Coadministration of COVID-19 and Influenza Vaccines.
JAMA Netw Open
; 6(9): e2332813, 2023 09 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37682571
16.
Humoral Response to the Fourth BNT162b2 Vaccination and Link Between the Fourth Dose, Omicron Infection, and Disease Severity in Renal Transplant Recipients.
Transplantation
; 107(1): 192-203, 2023 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36367927
17.
Humoral Immunity of Unvaccinated COVID-19 Recovered vs. Naïve BNT162b2 Vaccinated Individuals: A Prospective Longitudinal Study.
Microorganisms
; 11(7)2023 Jun 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-37512801
18.
Reduced Neutralization Efficacy against Omicron Variant after Third Boost of BNT162b2 Vaccine among Liver Transplant Recipients.
Viruses
; 15(1)2023 01 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-36680292
19.
Immunogenicity of Omicron BA.1-adapted BNT162b2 vaccines: randomized trial, 3-month follow-up.
Clin Microbiol Infect
; 29(7): 918-923, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-36921715
20.
Factors Associated With Protection From SARS-CoV-2 Omicron Variant Infection and Disease Among Vaccinated Health Care Workers in Israel.
JAMA Netw Open
; 6(5): e2314757, 2023 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37219906